Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.75 GBX | 0.00% | 0.00% | +34.04% |
Mar. 06 | Science in Sport annual revenue dips on lower trading | AN |
Mar. 06 | Science in Sport plc Provides Revenue Guidance for the Year 2024 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 63.67 | 52.5 | 47.28 | 91.32 | 23.49 | 28.39 | 28.39 | - |
Enterprise Value (EV) 1 | 55.67 | 48.21 | 36.82 | 86.47 | 23.49 | 50.89 | 48.75 | 46.12 |
P/E ratio | - | - | - | -13.7 x | -1.77 x | - | - | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.99 x | 1.04 x | 0.94 x | 1.46 x | - | 0.45 x | 0.45 x | 0.4 x |
EV / Revenue | 2.61 x | 0.95 x | 0.73 x | 1.38 x | - | 0.81 x | 0.77 x | 0.66 x |
EV / EBITDA | -21.8 x | -139 x | 33.5 x | 38.7 x | - | 25 x | 12.2 x | 7.69 x |
EV / FCF | -7.06 x | -19.7 x | - | -12.9 x | - | -664 x | 603 x | 463 x |
FCF Yield | -14.2% | -5.09% | - | -7.75% | - | -0.15% | 0.17% | 0.22% |
Price to Book | - | - | - | 2.1 x | - | - | - | - |
Nbr of stocks (in thousands) | 117,913 | 119,314 | 133,187 | 133,311 | 167,801 | 180,227 | 180,227 | - |
Reference price 2 | 0.5400 | 0.4400 | 0.3550 | 0.6850 | 0.1400 | 0.1575 | 0.1575 | 0.1575 |
Announcement Date | 3/20/19 | 3/18/20 | 3/17/21 | 3/29/22 | 6/29/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 21.32 | 50.57 | 50.35 | 62.54 | - | 62.75 | 63.55 | 70.13 |
EBITDA 1 | -2.548 | -0.347 | 1.1 | 2.234 | - | 2.039 | 4.004 | 5.996 |
EBIT 1 | -5.995 | -5.045 | -2.237 | -5.223 | - | -3.033 | -1.436 | 0.2519 |
Operating Margin | -28.12% | -9.98% | -4.44% | -8.35% | - | -4.83% | -2.26% | 0.36% |
Earnings before Tax (EBT) 1 | -5.99 | -5.064 | -2.273 | -5.337 | - | -4.754 | -3.149 | -1.224 |
Net income | - | - | - | - | -10.91 | - | - | - |
Net margin | - | - | - | - | - | - | - | - |
EPS | - | - | - | -0.0500 | -0.0790 | - | - | - |
Free Cash Flow 1 | -7.885 | -2.453 | - | -6.701 | - | -0.0767 | 0.0809 | 0.0996 |
FCF margin | -36.99% | -4.85% | - | -10.71% | - | -0.12% | 0.13% | 0.14% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 2.02% | 1.66% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 3/20/19 | 3/18/20 | 3/17/21 | 3/29/22 | 6/29/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 22.5 | 20.4 | 17.7 |
Net Cash position 1 | 8 | 4.29 | 10.5 | 4.85 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | 11.04 x | 5.086 x | 2.957 x |
Free Cash Flow 1 | -7.89 | -2.45 | - | -6.7 | - | -0.08 | 0.08 | 0.1 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | 0.3300 | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | 6.54 | - | - | - | - |
Capex / Sales | - | - | - | 10.46% | - | - | - | - |
Announcement Date | 3/20/19 | 3/18/20 | 3/17/21 | 3/29/22 | 6/29/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.04% | 35.36M | |
+8.20% | 7.78B | |
+0.34% | 7.38B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M |
- Stock Market
- Equities
- SIS Stock
- Financials Science in Sport plc